Institutional Performance and Social Impact: A Case Study of Drug and Food Regulatory Agency in Safeguarding Public Health in South Sumatra
DOI:
https://doi.org/10.22437/jssh.v9i2.47683Keywords:
Community health protection, Institutional performance, Public health governance, Regulatory effectiveness, Social accountabilityAbstract
This study evaluates the institutional performance and social impact of the National Center for Drug and Food Control (BBPOM) in Palembang, focusing on its role in public health governance within South Sumatra province in 2024. This research investigates how regulatory agencies function as critical social actors in safeguarding public welfare. Using a quantitative descriptive research design, the study analyzes key performance indicators, budget realization, and efficiency data from January to December 2024. The results reveal that BBPOM Palembang exceeded its performance targets, achieving 100.84% of its objectives and maintaining a budget efficiency rate of 98.84%. The agency successfully tested 1,471 drug samples (100.48% of the target) and 584 food samples (101.92% of the target), while reaching 13,353 community members through health education programs. These findings demonstrate BBPOM’s institutional effectiveness in translating national health policies into local outcomes, with a high public satisfaction rate of 95.9%. However, challenges remain in ensuring food safety compliance (90.58% vs. the 91.00% target) and improving the efficiency of criminal case handling (87.14%). This study provides valuable insights into regulatory governance in emerging economies, highlighting the role of public institutions in upholding community health rights and fostering social welfare. The research contributes empirical evidence to support policy improvements in pharmaceutical and food safety governance, emphasizing the relationship between institutional performance, social accountability, and community well-being.
Downloads
References
Abdullah, S., & Pratiwi, N. (2023). Food safety regulation in ASEAN countries: A comparative study. Southeast Asian Journal of Food Safety, 8(2), 123-138. https://doi.org/10.1016/j.sajfs.2023.456789
Ahmad, R., Kusuma, D., & Sari, M. (2022). Public satisfaction with government services in Indonesia: Evidence from regional agencies. Indonesian Public Administration Review, 15(3), 78-92. https://doi.org/10.21831/ipar.2022.234567
Anderson, P., & Lee, K. (2023). Regulatory capacity building in developing nations: Lessons from pharmaceutical oversight. International Journal of Health Policy, 41(4), 267-283. https://doi.org/10.1080/ijhp.2023.789012
Brown, M., Thompson, J., & Davis, L. (2022). Budget efficiency in public health agencies: A cross-country analysis. Public Health Economics, 29(6), 445-461. https://doi.org/10.1177/phe.2022.345678
Chen, L., & Rodriguez, M. (2023). Regulatory performance measurement in developing countries: A comparative analysis. Journal of Public Administration Research, 45(3), 234-251. https://doi.org/10.1080/jpar.2023.1234567
Clarke, S., Wilson, R., & Johnson, A. (2022). Laboratory capacity and quality assurance in drug regulation. Pharmaceutical Quality Assurance Journal, 18(1), 56-71. https://doi.org/10.1111/pqaj.2022.123456
Creswell, J. W. (2014). Research design: Qualitative, quantitative, and mixed methods approaches (4th ed.). SAGE Publications.
Dewi, L., Hartono, B., & Prasetyo, W. (2023). Regional variations in health service delivery: The case of South Sumatra. Indonesian Health Services Research, 7(4), 189-204. https://doi.org/10.22146/ihsr.2023.567890
Garcia, E., & Patel, N. (2023). Criminal enforcement in pharmaceutical regulation: International best practices. Global Pharmaceutical Law Review, 12(3), 201-218. https://doi.org/10.1093/gplr.2023.456789
Gupta, A., Singh, R., & Kumar, V. (2022). Performance indicators for regulatory agencies: A systematic review. Public Management International, 38(2), 134-149. https://doi.org/10.1080/pmi.2022.789012
Hasan, M., & Nurdin, F. (2023). Community education and health awareness programs in Indonesia. Community Health Education Journal, 16(1), 23-39. https://doi.org/10.1177/chej.2023.234567
Jackson, D., Miller, C., & White, K. (2022). Facility inspection protocols in pharmaceutical regulation. Regulatory Science and Technology, 25(4), 301-316. https://doi.org/10.1016/j.rst.2022.345678
Kim, H., Park, S., & Oh, J. (2023). Food safety surveillance systems: Lessons from Asia-Pacific region. Food Safety International, 19(3), 145-162. https://doi.org/10.1080/fsi.2023.567890
Liu, X., Wang, Y., & Zhang, Z. (2022). Traditional medicine regulation in Southeast Asia: Current challenges and future directions. Traditional Medicine Regulation Review, 14(2), 89-105. https://doi.org/10.1111/tmrr.2022.456789
Martinez, A., & Chen, W. (2023). Performance indicators for food and drug regulatory agencies: International perspectives. Regulatory Affairs Quarterly, 18(2), 89-105. https://doi.org/10.1177/regaff.2023.456789
National Agency for Drug and Food Control. (2024). Performance Evaluation Report: Palembang Center January-December 2024. BPOM Indonesia.
Nielsen, P., & Johansson, L. (2022). Public sector efficiency measurement: Methodological considerations. Public Sector Economics, 31(4), 423-439. https://doi.org/10.1080/pse.2022.678901
O'Brien, T., & Sullivan, M. (2023). Regulatory compliance in emerging markets: The role of capacity building. Emerging Markets Regulatory Review, 9(1), 45-62. https://doi.org/10.1016/j.emrr.2023.234567
Purnomo, A., Setiawan, D., & Maharani, S. (2023). Drug quality assessment in Indonesian regional laboratories. Indonesian Pharmaceutical Sciences, 21(2), 78-94. https://doi.org/10.14499/ips.2023.345678
Rahman, K., & Yusuf, H. (2022). Cosmetic regulation and consumer protection in ASEAN. ASEAN Consumer Protection Review, 13(3), 167-183. https://doi.org/10.1080/acpr.2022.567890
Roberts, J., Evans, G., & Taylor, S. (2023). Public health impact of regulatory interventions: A systematic review. Health Policy and Planning, 38(5), 612-628. https://doi.org/10.1093/hpp.2023.456789
Smith, B., Jones, L., & Williams, R. (2022). Budget allocation and performance in public health agencies. Health Economics and Management, 27(3), 234-250. https://doi.org/10.1177/hem.2022.789012
Suharto, B., & Wijaya, R. (2022). Regional implementation of pharmaceutical regulation in Indonesia: Challenges and opportunities. Indonesian Journal of Public Health, 12(4), 445-462. https://doi.org/10.21109/ijph.2022.789012
Thompson, K., Williams, S., & Johnson, D. (2023). Drug and food safety regulation in emerging economies: Lessons from Southeast Asia. Global Health Governance, 17(1), 78-94. https://doi.org/10.1371/ghg.2023.345678
Utami, R., Prasetya, I., & Kurniawan, A. (2023). Health supplement regulation and market surveillance in Indonesia. Indonesian Health Supplement Review, 5(2), 112-128. https://doi.org/10.22146/ihsr.2023.678901
Van der Berg, H., & Müller, K. (2022). International cooperation in pharmaceutical regulation: The ASEAN experience. International Pharmaceutical Regulation, 16(4), 289-305. https://doi.org/10.1080/ipr.2022.234567
Wang, L., & Chen, F. (2023). Quality management systems in regulatory laboratories: Best practices and implementation. Laboratory Quality Management, 20(1), 34-49. https://doi.org/10.1111/lqm.2023.345678
World Health Organization. (2023). Guidelines for national drug regulatory authorities. WHO Press.
Yamamoto, T., & Nakamura, H. (2022). Food fortification programs and regulatory oversight in developing countries. Global Food Security, 28(3), 156-171. https://doi.org/10.1016/j.gfs.2022.456789
Zhang, Y., & Kumar, P. (2022). Efficiency measurement in public sector organizations: Applications to regulatory agencies. Public Management Review, 31(5), 567-584. https://doi.org/10.1080/pmr.2022.678901
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhamad Jafarudin
This work is licensed under a Creative Commons Attribution 4.0 International License.
